(Q46171221)

English

Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

author name string

Shuchi Midha

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

Rakesh Bhatnagar

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

39

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

159-177

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax protective antigen: prepore-to-pore conversion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Mechanism of membrane translocation by anthrax toxin: insertion and pore formation by protective antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Manipulation of host signalling pathways by anthrax toxins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Genetic immunization against anthrax

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Class II MHC molecules can use the endogenous pathway of antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Cytoplasmic determinants involved in direct lysosomal sorting, endocytosis, and basolateral targeting of rat lgp120 (lamp-I) in MDCK cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

CD8 T cell priming by B lymphocytes is CD4 help dependent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Search for correlates of protective immunity conferred by anthrax vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Effector and memory T-cell differentiation: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Analysis of humoral immunity of hepatitis D virus DNA vaccine generated in mice by using different dosage, gene gun immunization, and in vivo electroporation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Characterization of the human immune response to the UK anthrax vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

In vitro correlate of immunity in a rabbit model of inhalational anthrax

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Immunologic adjuvants for modern vaccine formulations.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Expression and purification of the recombinant protective antigen of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Cortisone-evoked decrease of acid-β-galactosidase, β-glucuronidase, N-acetyl-β-glucosaminidase and arylsulphatase in the ileum of suckling rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

21 January 2018

Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological role of different antibody classes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

Reconstitution of the transport of protein between successive compartments of the Golgi measured by the coupled incorporation of N-acetylglucosamine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related effects of ectopic pituitary transplants on the activation of Ames dwarf mouse lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838058

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.200838058

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130551

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46171221&oldid=2097377979"